Research in mouse models of Fragile X syndrome has found that genetic or pharmacological reduction in mGluR5 signaling reduced abnormal behaviors in mice (Bear et al. 2008; Bear et al. 2004). The gene discussed is GRM5; the disease is fragile X syndrome.